|
Market Cap (3-Jul) $540,969,856 (160th) |
Close (30-Jun) $3.18 |
Volume (30-Jun) 1,248,327 |
Shortsold (19-Jun) 25,336,357 (3.49%) (70th) |
|
52w High $1.36 |
52w Low $0.73 |
P/E 67.57 |
EPS -0.96 |
A news article has been posted about Healius on the AFR. The article was published around , on 21 October 2021 at 10:03am.
The pathology player posted a 44 per cent jump in group revenue driven by COVID-19 testing and stronger than expected routine testing.
Read ArticleHLS was $4.55 at the close of trade on 20 October 2021
| Recent Articles about ASX:HLS | |
|---|---|
| 29-Jun | Labor threatens pathology giants with price fixing probe over fee hike
afr.com |
| 19-Dec | Ask the analyst: Why have Healius shares struggled so much?
morningstar.com.au |
| 18-Dec | Diagnostic Imaging Radiates Opportunity
fnarena.com |
| 17-Dec | Australian diagnostic company Healius sells Lumus Imaging for $657 million
akm.ru |
| 2-Dec | Healius Limited Announces Director Departure and Shareholdings
markets.businessinsider.com |
| 25-Nov | Healius Director Increases Stake with New Share Acquisition
nasdaq.com |
| 14-Nov | Healius Limited Refocuses Strategy with Leadership Changes
nasdaq.com |
| 27-Sep | Scott Power: Which health ‘underperformer’ just made a big move?
stockhead.com.au |
| 27-Sep | HSF acts for Healius Limited on $965m sale of Lumus Imaging to Affinity Equity Partners
thelawyermag.com |
| 25-Sep | Jarden upgrades Healius Limited (PGZ) to a Hold
markets.businessinsider.com |
| Tracked |
Find all articles about Healius, including others on the AFR, on the media page.
You must be logged in to post a reply.
